Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Sunitinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 6 Gastrointestinal Stromal Tumors 4 Multiple Myeloma 3 Urologic Neoplasms 2 Osteosarcoma 2 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Kidney Neoplasms 2 Gastrointestinal Neoplasms 2 Adenoma, Islet Cell 2 Uveal Melanoma 1 Sarcoma, Alveolar Soft Part 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Lymphoma 1 Kidney Diseases 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoma 1 Carcinoid Tumor 1

Interventions

exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Anastrozole 2 ribociclib 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Neoadjuvant Therapy 1 Immunoenzyme Techniques 1 Everolimus 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡